Quanterix (NASDAQ:QTRX) Releases Quarterly Earnings Results, Misses Estimates By $0.13 EPS

Quanterix (NASDAQ:QTRX) issued its quarterly earnings results on Monday. The company reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.23) by ($0.13), Zacks reports. Quanterix had a negative return on equity of 21.37% and a negative net margin of 73.47%.The business had revenue of $40.23 million during the quarter, compared to analysts’ expectations of $37.85 million. Quanterix updated its FY 2025 guidance to EPS.

Quanterix Trading Up 4.2%

Shares of NASDAQ:QTRX traded up $0.21 on Wednesday, reaching $5.21. The company had a trading volume of 39,633 shares, compared to its average volume of 719,921. The firm has a market capitalization of $242.09 million, a PE ratio of -2.25 and a beta of 1.12. Quanterix has a 52-week low of $4.05 and a 52-week high of $15.46. The firm’s 50 day simple moving average is $5.35 and its 200-day simple moving average is $5.47.

Analyst Ratings Changes

Several research firms recently commented on QTRX. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quanterix in a research note on Wednesday, October 8th. Canaccord Genuity Group reaffirmed a “hold” rating and set a $5.00 target price (down from $12.00) on shares of Quanterix in a research report on Monday, August 11th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $11.75.

Institutional Trading of Quanterix

Several hedge funds have recently modified their holdings of the company. Balyasny Asset Management L.P. raised its stake in shares of Quanterix by 1,625.2% during the 2nd quarter. Balyasny Asset Management L.P. now owns 767,801 shares of the company’s stock worth $5,106,000 after acquiring an additional 723,295 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in Quanterix by 14.0% in the second quarter. Ameriprise Financial Inc. now owns 4,236,877 shares of the company’s stock worth $28,175,000 after purchasing an additional 521,639 shares during the last quarter. Marshall Wace LLP purchased a new stake in shares of Quanterix during the 2nd quarter valued at $2,954,000. Vanguard Group Inc. boosted its position in shares of Quanterix by 4.7% in the 3rd quarter. Vanguard Group Inc. now owns 2,647,515 shares of the company’s stock worth $14,376,000 after purchasing an additional 118,565 shares in the last quarter. Finally, Jane Street Group LLC grew its stake in Quanterix by 140.0% during the 2nd quarter. Jane Street Group LLC now owns 139,964 shares of the company’s stock worth $931,000 after buying an additional 81,651 shares during the last quarter. 86.48% of the stock is owned by hedge funds and other institutional investors.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.